Preceptorship in Multiple Sclerosis, 23rd (Ed. 2025)
With new insights into the pathogenesis of demyelinating diseases, the development of innovative tools to improve diagnosis and a greater availability of new treatment methods in clinical practice, neurologists specializing in multiple sclerosis are compelled to stay up to date with all the latest developments and ideas about best practices.
Objetivos generales
This course given by specialists in multiple sclerosis provides the opportunity to share their knowledge and help fellow neurologists understand the most recent research in diagnosis, treatment, patient management and rehabilitation with top MS faculty members. This will enable neurologists to be better equipped to adapt and optimize their daily practices according to the needs of their patients.
Este curso está acreditado con 9,5 créditos (ECMEC®s) por la European Accreditation Council for Continuing Medical Education (EACCME®).
Sesión 01
| Programa | MSP23 |
|---|---|
| Día / Hora | 15/12/2025 | 09:30 H - 17:00 H |
| Ponencias |
Welcome Ponente: Xavier Montalban
Immunopathogenesis of Multiple Sclerosis Ponente: Heinz Wiendl
Hystopathology of Multiple Sclerosis Ponente: Tanja Kuhlmann
Aging and Immunosenescence in MS Ponente: Vincent van Pesch
Clinical Diagnosis of Multiple Sclerosis: criteria and beyond Ponente: Mar Tintoré
A new framework for MS classification Ponente: Alan Thompson
Differential Diagnosis of Multiple Sclerosis Ponente: Georgina Arrambide
Value of optic nerve study in Multiple Sclerosis diagnosis Ponente: Ángela Vidal
Cognitive Impairment of Multiple Sclerosis Ponente: Maria Pia Amato
Brain & spinal cord reserve in Multiple Sclerosis Ponente: Jaume Sastre-Garriga
Visit to the Centre |
Sesión 02
| Programa | MSP23 |
|---|---|
| Día / Hora | 16/12/2025 | 09:30 H - 16:00 H |
| Ponencias |
Neuromyelitis optica Ponente: Friedemann Paul
Myelin oligodendrocite glypoprotein antibody associated disease (MOGAD) Ponente: Romain Marignier
Pediatric and juvenile Multiple Sclerosis Ponente: Yael Hacohen
Imaging in Multiple Sclerosis Ponente: Àlex Rovira
Biomarkers in Multiple Sclerosis Ponente: Manuel Comabella
Artificial Intelligence in Multiple Sclerosis Ponente: Carmen Tur
Overview of treatments and treatment algorithms Ponente: Xavier Montalban
Safety of DMD’s Ponente: Fredrik Piehl
Vaccines and MS Ponente: Susana Otero
Future treatments Ponente: Xavier Montalban |